Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
ToppCellPBMC-Mild-Myeloid-Neutrophil-Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ADAMTSL1 RD3

2.03e-0410892c647f6595e7cccea91429a2377c9de6cc1acff4d
ToppCell3'_v3-blood-Lymphocytic_T_CD4-Trm_Th1/Th17|blood / Manually curated celltypes from each tissue

RHOBTB1 LRP12

4.07e-0415392d09bc7322b59f613d66673359ee6af1aea99ce87
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP12 KATNIP

4.79e-0416692fb2cfbf1d0a0f1950dd24c08ba00ebd64b06ceb4
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RD3 KATNIP

5.02e-0417092f3d5678669dcaed1836014cea543758b7ccc6b46
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass

RHOBTB1 KATNIP

5.14e-0417292f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTSL1 RHOBTB1

5.26e-0417492ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTSL1 RHOBTB1

5.26e-0417492b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 LRP12

5.32e-04175920801cccec6915aefc135262fc74580280fd51aa5
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 LRP12

5.32e-041759209163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTSL1 RHOBTB1

5.38e-041769240993c41c1017b53039a337174fc56632b278609
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTSL1 RHOBTB1

5.44e-0417792f902600c639087664316b3cf30cab243bc3d1c5c
ToppCellInfluenza_Severe-Platelet|Influenza_Severe / Disease group and Cell class

RHOBTB1 LRP12

5.69e-04181924d037b098bb6f780ed8b15c0ec23a6f4d86bf45a
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL1 RHOBTB1

5.69e-0418192b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL1 RHOBTB1

5.69e-0418192cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCellfacs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL1 RHOBTB1

5.69e-0418192ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCelldroplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 RHOBTB1

5.94e-041859264791056cdbb739136dbef08f4b16e2b5427faad
ToppCelldroplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 RHOBTB1

5.94e-04185926a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCellsevere_influenza-Platelet|World / disease group, cell group and cell class (v2)

RHOBTB1 LRP12

6.13e-0418892b54632baa682aaf51100d44e7f114a54d5edd695
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

NKTR RHOBTB1

6.20e-0418992a48df46274d51e84ffb40264646de7346104efb9
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTSL1 RD3

6.46e-04193924ccf984baebbb13ae916727137ce593fda7514a2
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTSL1 RD3

6.46e-0419392f27e2be497745098b5269aa799dd3d5f62d78ba7
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKTR RHOBTB1

6.46e-0419392471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKTR RHOBTB1

6.46e-0419392fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCelldroplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKTR RHOBTB1

6.53e-04194923a3ecedcdc7691cf21775818b598208fcb980c29
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NKTR RHOBTB1

6.53e-04194920b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRDM15 KATNIP

6.73e-0419792789c97ca9d1e28df3353140046047f11fbccc1d0
ToppCellParenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

RHOBTB1 LRP12

6.80e-0419892cc2b5b632e73e44bb60050f0db10d8f0dbb859fa
ToppCellInfluenza-Influenza_Severe-Others-Platelet|Influenza_Severe / Disease, condition lineage and cell class

RHOBTB1 LRP12

6.93e-0420092548e8e2f0e4225827db58b0c8b05221f18ae482b
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

ADAMTSL1 RHOBTB1

6.93e-0420092fae26560ba3b0b638b6bcf92f05330824b31d21b
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic

ADAMTSL1 RHOBTB1

6.93e-0420092f75d95376a340d467c4392b872b2a2dbdd184556
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic

ADAMTSL1 RHOBTB1

6.93e-042009247791c93d03ee17c1ce17e27f075be4fc6f2590e
DrugOxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A

NKTR LRP12 KATNIP

5.08e-05196932103_DN
DrugGDP-Man

NKTR ADAMTSL1

1.31e-0314092CID000000732
DrugICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA

NKTR RHOBTB1

2.20e-03182921043_DN
DrugDilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A

RHOBTB1 LRP12

2.28e-03185924688_DN
DrugApigenin [520-36-5]; Down 200; 14.8uM; PC3; HT_HG-U133A

RHOBTB1 LRP12

2.30e-03186924578_DN
DrugMyricetin [529-44-2]; Up 200; 12.6uM; HL60; HT_HG-U133A

NKTR LRP12

2.30e-03186921334_UP
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

NKTR LRP12

2.30e-03186925597_UP
DrugEthotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A

NKTR LRP12

2.35e-03188924545_DN
DrugMethiothepin maleate [19728-88-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.37e-03189923231_UP
DrugLY 294002; Up 200; 10uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.37e-03189925587_UP
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

RHOBTB1 LRP12

2.37e-03189921168_DN
DrugDeltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A

NKTR LRP12

2.40e-03190924306_DN
DrugTolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A

NKTR LRP12

2.40e-03190924362_DN
DrugSulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A

NKTR LRP12

2.40e-03190924322_DN
DrugDigoxin [20830-75-5]; Down 200; 5.2uM; PC3; HT_HG-U133A

NKTR RHOBTB1

2.42e-03191926724_DN
DrugMefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A

LRP12 KATNIP

2.42e-03191922048_DN
DrugNorgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A

NKTR RHOBTB1

2.42e-03191924269_DN
DrugMeticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A

NKTR LRP12

2.45e-03192921792_UP
Drug0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A

GHRHR NKTR

2.45e-03192923858_UP
DrugFolinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A

NKTR LRP12

2.47e-03193924725_UP
DrugButylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A

GHRHR KATNIP

2.47e-03193925608_DN
DrugD-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A

NKTR KATNIP

2.47e-03193923562_DN
DrugAstemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A

LRP12 KATNIP

2.47e-03193922049_DN
DrugImipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A

NKTR KATNIP

2.47e-03193925440_DN
DrugGuanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A

LRP12 KATNIP

2.47e-03193925256_DN
DrugIsradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A

NKTR KATNIP

2.50e-03194926347_DN
DrugRoxarsone [121-19-7]; Down 200; 15.2uM; PC3; HT_HG-U133A

NKTR KATNIP

2.50e-03194925051_DN
DrugPridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A

LRP12 KATNIP

2.50e-03194927214_DN
DrugEtifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A

NKTR LRP12

2.50e-03194922838_UP
DrugLevonordefrin [829-74-3]; Down 200; 21.8uM; PC3; HT_HG-U133A

RHOBTB1 KATNIP

2.50e-03194925854_DN
DrugFamprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A

NKTR LRP12

2.50e-03194924309_DN
DrugCP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A

NKTR LRP12

2.53e-03195924382_UP
Drugprochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA

NKTR KATNIP

2.53e-03195921053_DN
DrugEthopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.53e-03195923376_DN
DrugMetolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.53e-03195925392_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A

GHRHR LRP12

2.53e-03195921732_UP
DrugClozapine [5786-21-0]; Down 200; 12.2uM; HL60; HT_HG-U133A

RHOBTB1 KATNIP

2.55e-03196921289_DN
Drugrosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.55e-03196925593_UP
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA

NKTR LRP12

2.55e-03196921024_DN
DrugNocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A

NKTR LRP12

2.55e-03196922239_DN
DrugEquilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.55e-03196925255_UP
DrugSuxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.55e-03196926065_DN
Drugindomethacin, USP; Up 200; 100uM; SKMEL5; HG-U133A

NKTR LRP12

2.55e-0319692503_UP
Drug2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A

NKTR LRP12

2.55e-03196921181_UP
DrugHymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.55e-03196923383_DN
Drug(d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.55e-03196922818_UP
DrugTranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A

GHRHR NKTR

2.55e-03196922101_UP
DrugBuflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; HL60; HT_HG-U133A

RHOBTB1 LRP12

2.55e-03196921338_DN
DrugMetanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.55e-03196921515_UP
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

RHOBTB1 KATNIP

2.55e-03196921054_DN
DrugHeliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A

NKTR LRP12

2.55e-03196924739_DN
DrugMenadione [58-27-5]; Down 200; 23.2uM; HL60; HT_HG-U133A

NKTR RHOBTB1

2.58e-03197922439_DN
DrugThalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A

LRP12 KATNIP

2.58e-03197922095_DN
DrugMonocrotaline [315-22-0]; Down 200; 12.2uM; HL60; HG-U133A

NKTR LRP12

2.58e-03197921757_DN
DrugOxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; HL60; HT_HG-U133A

LRP12 KATNIP

2.58e-03197926145_DN
DrugAmoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HG-U133A

NKTR LRP12

2.58e-03197921931_DN
DrugAmethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.58e-03197923214_UP
DrugChlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.58e-03197925493_DN
Drugtrifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A

NKTR KATNIP

2.58e-03197926984_DN
DrugFlavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A

LRP12 KATNIP

2.58e-03197926326_DN
Drug0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A

RHOBTB1 LRP12

2.58e-03197924758_UP
DrugScoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

NKTR LRP12

2.58e-03197925536_DN
DrugCarbachol [51-83-2]; Down 200; 21.8uM; HL60; HT_HG-U133A

RHOBTB1 LRP12

2.58e-03197923042_DN
DrugFenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A

NKTR LRP12

2.58e-03197922308_UP
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A

NKTR LRP12

2.58e-03197924764_DN
Drugclozapine; Up 200; 10uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.58e-03197925589_UP
Drugfluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA

LRP12 KATNIP

2.58e-03197921017_DN
DrugBudesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

RHOBTB1 LRP12

2.60e-03198925431_DN
DrugTrimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A

NKTR LRP12

2.60e-03198922002_DN
DrugLoxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.60e-03198921516_UP
DrugMebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198924694_DN
DrugBromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198926037_UP
DrugBetonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A

NKTR LRP12

2.60e-03198924301_UP
DrugButylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.60e-03198926446_UP
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

NKTR KATNIP

2.60e-03198921650_DN
DrugSulfinpyrazone [57-96-5]; Up 200; 9.8uM; HL60; HG-U133A

NKTR LRP12

2.60e-03198921574_UP
DrugRamipril [87333-19-5]; Down 200; 9.6uM; PC3; HT_HG-U133A

NKTR LRP12

2.60e-03198927144_DN
DrugAltretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A

NKTR RHOBTB1

2.60e-03198925688_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198924348_DN
DrugOfloxacin [82419-36-1]; Up 200; 11uM; HL60; HT_HG-U133A

LRP12 KATNIP

2.60e-03198922340_UP
DrugYohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198926777_UP
DrugOrphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.60e-03198923883_UP
DrugBezafibrate [41859-67-0]; Down 200; 11uM; HL60; HT_HG-U133A

RHOBTB1 KATNIP

2.60e-03198921275_DN
DrugPF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A

NKTR RHOBTB1

2.60e-03198926907_UP
DrugNilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198926481_UP
DrugMetampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.60e-03198922286_UP
DrugDL-PPMP; Up 200; 2uM; MCF7; HT_HG-U133A_EA

NKTR RHOBTB1

2.60e-03198921121_UP
DrugHyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198925524_DN
DrugOxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198925410_UP
DrugNitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A

GHRHR LRP12

2.60e-03198924697_UP
DrugApramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A

LRP12 KATNIP

2.60e-03198927334_DN
DrugMoxalactam disodium salt [64953-12-4]; Down 200; 7uM; MCF7; HT_HG-U133A

NKTR LRP12

2.60e-03198925609_DN
DrugTerazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; HL60; HT_HG-U133A

RHOBTB1 LRP12

2.63e-03199922530_DN
DrugSulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A

RHOBTB1 LRP12

2.63e-03199922550_DN
DiseaseMyopia

ADAMTSL1 LRP12 KATNIP

1.18e-0438583HP_0000545
Diseaseasthma, response to diisocyanate

ADAMTSL1 RD3

2.11e-0326182EFO_0006995, MONDO_0004979
DiseaseR-warfarin measurement

ADAMTSL1 KATNIP

2.17e-0326582EFO_0803324
Diseasewhite matter hyperintensity measurement

PRDM15 RD3

2.81e-0330282EFO_0005665
Diseasechronic obstructive pulmonary disease

ADAMTSL1 PRDM15

1.38e-0268882EFO_0000341
Diseaseprostate carcinoma

SDHAF4 ADAMTSL1

2.26e-0289182EFO_0001663

Protein segments in the cluster

PeptideGeneStartEntry
MACRWSTKESPRWRS

LRP12

1

Q9Y561
DTWSSRTPSRSRWRS

KATNIP

876

O60303
NRRDCPSRWMVTSWS

ADAMTSL1

1541

Q8N6G6
KTPRGSWRWSRSFHL

FAM205A

1091

Q6ZU69
RRFRTWPSATSWERR

HRES1

76

P13985
LASTSPSSRRAFWWL

GHRHR

231

Q02643
AWRTRAKWTTPSRSA

GHRHR

401

Q02643
SWVSATAWRAARSPL

SDHAF4

11

Q5VUM1
RWDERSLSQRSRSWS

NKTR

396

P30414
HRWRSESKPGWISRS

PRDM15

56

P57071
WLRWNEAPSRLSTRS

RD3

6

Q7Z3Z2
RSRRKWCFWNSSPAV

RHOBTB1

681

O94844
FRRWARKWSRFTRSS

nan

81

Q6ZVQ6